precision medicine

New strategies for managing drug spend: RA, Cancer, Hep C
New strategies for managing drug spend: RA, Cancer, Hep CThe proliferation of specialty drugs has prompted new techniques for keeping costs in tow.
How precision medicine is improving patient lives: Real examplesAn expert at the Precision Medicine World Conference shared cancer patient perspectives on the importance of immuno-oncology and breakthrough targeted therapies and how they have extended their lives.
Where will precision medicine go in 2017?
Where will precision medicine go in 2017?While the future of the Precision Medicine Initiative is uncertain as we enter into a new presidential term, how can we as clinicians implement tenets of precision medicine right now when treating our patients?
Top barriers to fully utilizing precision medicine biomarkersAs development of molecular biomarkers hastens, administrators, clinicians and regulators are working to organize and define biomarkers’ appropriate roles in clinical care—and discussing how to efficiently share the massive amounts of genomic data that will result.
Top 10 sessions to attend at ASH 2016This year’s American Society of Hematology (ASH) Conference, held in San Diego, will feature a wide array of sessions.
Six ways precision medicine is improving care
Six ways precision medicine is improving careHere are some of the latest precision medicine approaches being used by managed care organizations, health systems and academic medical centers across the U.S.
Independence Blue Cross president: Why we cover whole genome sequencingAfter carefully considering its promise and consulting with experts, Independence Blue Cross this year became the first major insurer to provide coverage for certain members who are seeking access to whole genome sequencing.
Cancer MoonShot 2020 will arm oncologists with new tools
Cancer MoonShot 2020 will arm oncologists with new toolsThe Cancer MoonShot 2020 program brings together stakeholders from pharma, community and academic oncology, as well as government and scientific communities in an effort to accelerate the potential of combination immunotherapy as the next-generation standard of care in cancer patients.
Obama’s precision medicine initiative: an updateThe precision medicine effort could dramatically change patient care, but will it be effective?
Beyond ACOs Alternative payment models of the futureWhy today’s models will always be interim ones—and how the consumerization of healthcare will drive change.